ifosfamide has been researched along with Mental Disorders in 2 studies
Mental Disorders: Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, S | 1 |
| Hayashi, Y | 1 |
| Nishida, S | 1 |
| Fujii, H | 1 |
| Nakamura, M | 1 |
| Yoshikura, N | 1 |
| Nagano, A | 1 |
| Kitagawa, J | 1 |
| Kanemura, N | 1 |
| Mizutani, K | 1 |
| Kobayashi, R | 1 |
| Ishihara, T | 1 |
| Hayashi, H | 1 |
| Shimohata, T | 1 |
| Sugiyama, T | 1 |
| Suzuki, A | 1 |
| Heim, ME | 1 |
| Fiene, R | 1 |
| Schick, E | 1 |
| Wolpert, E | 1 |
| Queisser, W | 1 |
2 other studies available for ifosfamide and Mental Disorders
| Article | Year |
|---|---|
Albumin-bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bilirubin; Creatine; | 2021 |
Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma.
Topics: Adult; Aged; Central Nervous System Diseases; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney N | 1981 |